myo-Inositol monoorthoformate | CAS:98510-20-4
myo-Inositol monoorthoformate
- 名称:myo-肌醇单原甲酸酯 | myo-Inositol monoorthoformate
- CAS号:98510-20-4
- 别名:1,3,5-O-Methylidyne-myo-inositol
- 分子式:C7H10O6
- 分子量:190.15
- EINESC号:
产品描述
物理化学性质
熔点 | 149-152 ºC** |
---|---|
密度 | 1.836±0.06 g/cm3 (20 º |
安全数据
没有数据 | 没有数据 |
---|
SDS
来源 | SDS样本 |
---|---|
没有数据 | 没有数据 |
产品合成路线
更多
名称 | CAS号 |
---|
更多
文章
同行评议文献
A rapid and reliable method for the quantitation of hydroxychloroquine in serum using turbulent flow liquid chromatography-tandem mass spectrometryFuzery AK, et al. Clinica Chimica Acta; International Journal of Clinical Chemistry, 421 (2013)
Development of a novel ion-pairing HPLC-FL method for the separation and quantification of hydroxychloroquine and its metabolites in whole bloodCharlier B,et al. Biomedical Chromatography, 32(8), e4258-e4258 (2018)
QUALITY BY DESIGN IN THE DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD BY ULTRAVIOLET-VISIBLE SPECTROPHOTOMETRY FOR QUANTIFICATION OF HYDROXYCHLOROQUINE SULFATEFerraz LRM, et al. International Journal of Pharmaceutical Sciences and Research, 5(11), 4666-4666 (2014)
Hydroxychloroquine SulfateBritish Pharmacopeia, 2021 British Pharmacopoeia, 44(12), 1000-1004 (2021)
Compatibility study of hydroxychloroquine sulfate with pharmaceutical excipients using thermal and nonthermal techniques for the development of hard capsulesMoraes ANF, et al. Journal of Thermal Analysis and Calorimetry, 421 (2019)
Pharmacokinetics and bioequivalence study of hydroxychloroquine sulfate tablets in Chinese healthy volunteers by LC--MS/MSFan HW, et al. Rheumatology and therapy, 2(2) (2015)
Analytical interference of quinolone antibiotics and quinine derived drugs on urinary protein determined by reagent strips and the pyrogallol red-molybdate protein assayda Silva AS and Falkenberg M Clinical Biochemistry, 44(12) (2011)
Seminars in Arthritis and Rheumatism, 43(2), 264-272 (2013)
备注
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
名称 | CAS号 |
---|
相关产品
相关资讯
问
热门标签
询 单
请 填 写 相 关 信 息
- 请填写产品名称!
- CAS号
- 请正确填写公司名称!
- 请正确填写联系人!
- 请正确填写联系电话!
- 请正确填写联系邮箱!
- 请描述您的问题!